BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2
16 results:

  • 1. Long-term treatment results of conventional and hypofractionation radiotherapy in postmastectomy cancer breast patients: A retrospective study from rural cancer center of Maharashtra, India.
    Jain VS; Bakshi N; Jain SM; Mandloi V; Malik Y; Kharde A
    J Cancer Res Ther; 2024 Jan; 20(1):396-403. PubMed ID: 38554352
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. lmo2 attenuates glycolytic metabolism and facilitates cytotoxic T-lymphocyte infiltration in the tumor environment of lung and breast cancers.
    Wang W; Meng Y; Yu Y; Wang H; Sun W
    Biochem Biophys Res Commun; 2023 Oct; 675():170-176. PubMed ID: 37480698
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of a minority population of lmo2
    Sikandar SS; Gulati GS; Antony J; Fetter I; Kuo AH; Ho WHD; Haro-Acosta V; Das S; Steen CB; Pereira TA; Qian D; Beachy PA; Dirbas FM; Red-Horse K; Rabbitts TH; Thiery JP; Newman AM; Clarke MF
    Sci Adv; 2022 Nov; 8(45):eabm3548. PubMed ID: 36351009
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. KDM3B-ETF1 fusion gene downregulates lmo2 via the WNT/β-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma.
    Hu A; Hong F; Li D; Xie Q; Chen K; Zhu L; He H
    Cancer Gene Ther; 2022 Feb; 29(2):215-224. PubMed ID: 33828234
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Microarray data analysis reveals gene expression changes in response to ionizing radiation in MCF7 human breast cancer cells.
    Bai J; Luo Y; Zhang S
    Hereditas; 2020 Sep; 157(1):37. PubMed ID: 32883354
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Prospective Trial to Compare Deep Inspiratory Breath Hold With Prone breast Irradiation.
    Gerber NK; Yan SX; Levinson BA; Perez CA; Das IJ; Maisonet OG; Huppert N; No DK; Kelley J; Mistry N; Hitchen CJ; Goldberg JD
    Pract Radiat Oncol; 2020; 10(5):330-338. PubMed ID: 32014615
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. lmo2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.
    Parvin S; Ramirez-Labrada A; Aumann S; Lu X; Weich N; Santiago G; Cortizas EM; Sharabi E; Zhang Y; Sanchez-Garcia I; Gentles AJ; Roberts E; Bilbao-Cortes D; Vega F; Chapman JR; Verdun RE; Lossos IS
    Cancer Cell; 2019 Sep; 36(3):237-249.e6. PubMed ID: 31447348
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. lmo2 Enhances Lamellipodia/Filopodia Formation in Basal-Type breast cancer Cells by Mediating ARP3-Profilin1 Interaction.
    Liu Y; Wu C; Zhu T; Sun W
    Med Sci Monit; 2017 Feb; 23():695-703. PubMed ID: 28170369
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. lmo2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling.
    Liu Y; Wang Z; Huang D; Wu C; Li H; Zhang X; Meng B; Li Z; Zhu T; Yang S; Sun W
    Oncotarget; 2017 Feb; 8(6):9513-9524. PubMed ID: 27880729
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. lmo2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer.
    Liu Y; Huang D; Wang Z; Wu C; Zhang Z; Wang D; Li Z; Zhu T; Yang S; Sun W
    Sci Rep; 2016 Oct; 6():36050. PubMed ID: 27779255
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells.
    Yong T; Sun A; Henry MD; Meyers S; Davis JN
    J Cell Biochem; 2011 Sep; 112(9):2340-51. PubMed ID: 21520243
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The transcription factor lmo2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
    Gratzinger D; Zhao S; West R; Rouse RV; Vogel H; Gil EC; Levy R; Lossos IS; Natkunam Y
    Am J Clin Pathol; 2009 Feb; 131(2):264-78. PubMed ID: 19141387
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.
    Aoyama M; Ozaki T; Inuzuka H; Tomotsune D; Hirato J; Okamoto Y; Tokita H; Ohira M; Nakagawara A
    Cancer Res; 2005 Jun; 65(11):4587-97. PubMed ID: 15930276
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent.
    Giatromanolaki A; Koukourakis MI; Simopoulos C; Polychronidis A; Gatter KC; Harris AL; Sivridis E
    Clin Cancer Res; 2004 Dec; 10(23):7972-7. PubMed ID: 15585632
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas.
    Sutherland KD; Visvader JE; Choong DY; Sum EY; Lindeman GJ; Campbell IG
    Int J Cancer; 2003 Oct; 107(1):155-8. PubMed ID: 12925972
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Fine needle aspiration of 184 mammary cysts (author's transl)].
    Mülberger G; Lauth G
    MMW Munch Med Wochenschr; 1975 May; 117(22):947-50. PubMed ID: 807809
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.